申请人:TAKEDA CHEMICAL INDUSTRIES, LTD.
公开号:EP0712845A1
公开(公告)日:1996-05-22
A compound of the formula:
wherein Ar¹ and Ar² independently present an optionally substituted aromatic group; P and Q independently represent a divalent aliphatic hydro-carbon group having at least 2 carbon atoms and optionally having ether oxygen or sulfur in the carbon chain; R¹ and R³ independently represent -CO-R, -CONH-R (R represents a hydrocarbon group or a heterocyclic group) or a hydrocarbon group; R² and R⁴ independently represent hydrogen or an alkyl group; R² and R⁴ independently represent hydrogen or an alkyl group; R¹ and R² or R³ and R⁴, taken together with the adjacent nitrogen atom, may form a nitrogen-containing heterocyclic group; and j represents 0 or 1, or a salt thereof has excellent GnRH-receptor antagonizing activity and is useful as a prophylactic and therapeutic agent for hormone-dependent and other diseases.
式中的化合物:
其中 Ar¹ 和 Ar² 独立地表示任选取代的芳香族基团;P 和 Q 独立地表示至少具有 2 个碳原子且碳链中任选具有醚氧或硫的二价脂族碳氢基团;R¹ 和 R³ 独立地表示-CO-R、-CONH-R(R 表示烃基或杂环基)或烃基;R² 和 R⁴ 独立地代表氢或烷基;R² 和 R⁴ 独立地代表氢或烷基;R¹ 和 R² 或 R³ 和 R⁴ 与相邻的氮原子一起可形成含氮杂环基团;以及 j 代表 0 或 1,或其盐具有优异的 GnRH 受体拮抗活性,可用作激素依赖性疾病和其他疾病的预防和治疗药物。